9 DNA Vaccines

SW Han, JZ de Moraes, CL Silva… - … DNA: methods and …, 2002 - books.google.com
Experimental nucleic acid vaccines have been the subject of considerable attention in
recent years because of their theoretical potential to achieve effects similar to live attenuated …

Impfung gegen HPV: Aktueller Stand und neue Perspektiven zur Vakzinierung gegen humanpathogene Papillomviren

TA Grubert, K Friese - Der Gynäkologe, 2003 - Springer
Dass humanpathogene Papillomviren das ursächliche Agens bei der Entstehung von
Zervixkarzinomen sind, ist heute aufgrund vieler epidemiologischer und experimenteller …

Therapeutic human papillomavirus vaccines

M Ling, TC Wu - Cercival Cancer: From Etiology to Prevention, 2004 - Springer
Pre-existing HPV infection is a highly prevalent public health concern that is responsible for
considerable morbidity and mortality. Evidence suggests that cellular immunity, particularly …

[PDF][PDF] Prophylaktische und therapeutische DNA-Immunisierung gegen das humane Papillomvirus 16

C Leder - 2003 - repo.uni-hannover.de
… Wir bekennen es vielmehr frei: was nach gänzlicher Aufhebung des Willens übrig bleibt,
ist für alle Die, welche noch des Willens voll sind, allerdings Nichts. Aber auch umgekehrt ist …

[PDF][PDF] 8. Impact of prophylactic HPV vaccination on the cervical cancer incidence and mortality. Perspectives for development of therapeutic HPV vaccines

V Madrid-Marina, EG Olea… - Research Signpost, 2015 - researchgate.net
In this Chapter we will discuss the current status of the prophylactic HPV vaccination, the
introduction of HPV prophylactic vaccination and its impact on the cervical cancer incidence …

The role of vaccines in cancer prevention

SN Khleif, H Frederickson - Cancer Chemoprevention, 2001 - Springer
From 1796, when Edward Jenner infected a young boy with cowpox in hopes of preventing
smallpox, to the present day, vaccinations have changed the incidence of many diseases …

Squamous cell and adeno cancer antigens recognized by cytotoxic T lymphocytes

K Itoh, S Shichijo, A Yamada, M Ito, T Mine… - … Recognized by T …, 2003 - taylorfrancis.com
Recent advances of molecular immunology allowed us to identify genes encoding human
tumor-associated antigens (TAAs) and peptides that are recognized by CD8 cytotoxic T …

[PDF][PDF] DEVELOPMENT OF HPV VACCINES

K Devaraj, ML Gillison, TC Wu - 2003 - Citeseer
High-risk genotypes of the human papillomavirus (HPV), particularly HPV type 16, are found
in a distinct subset of head and neck squamous cell carcinomas (HNSCC). Thus, these HPV …

Genetic approaches for biologic therapy of cancer.

A Gambotto, V Cicinnati, PD Robbins - Drugs of Today (Barcelona …, 2000 - europepmc.org
Recently, there has been an increase in the types of biological therapeutic approaches
developed for the treatment of cancer. This rapid advance in the biological therapy of cancer …

Immunity to human papillomaviruses: implications for vaccine design

JC Steele - Perspectives in Medical Virology, 2001 - Elsevier
Publisher Summary This chapter reviews the human immune responses against human
papillomaviruses (HPVs) and discusses the development of immunotherapeutic strategies …